Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2014
10/07/2014US8852637 Extracellular matrix compositions for the treatment of cancer
10/07/2014US8852636 Pharmaceutical compositions for the coordinated delivery of NSAIDs
10/07/2014US8852635 Pharmaceutical compositions of fenofibrate
10/07/2014US8852634 Dosage formulation
10/07/2014US8852633 Orodispersible domperidone tablets
10/07/2014US8852632 Pharmaceutical formulation containing a release rate controlling composition
10/07/2014US8852626 Controlled-release CNS modulating compositions and methods for the treatment of otic disorders
10/07/2014US8852624 Biomedical implants comprising surface-modified ceramic particles and biodegradable stereo complex polymers, its use for suppressing inflammation and improvement of mechanical property, and preparation method thereof
10/07/2014US8852623 Implantable polymeric device for sustained release of dopamine agonist
10/07/2014US8852615 Clear, greaseless skin-care compositions
10/07/2014US8852605 Vibrio cholerae O139 conjugate vaccines
10/07/2014US8852602 Immunological herpes simplex virus antigens and methods for use thereof
10/07/2014US8852590 Compositions and methods for treating cancer
10/07/2014US8852569 Prevention and treatment of itch with cysteine protease inhibition
10/07/2014US8852568 Compositions and methods for treating and preventing skeletal muscle deficiencies
10/07/2014US8852566 Compositions and methods for preferential distribution of active agents to injury sites
10/07/2014US8852559 Borinic compositions
10/07/2014US8852558 In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide and platinum catalyst
10/07/2014US8852151 Swallowable drug delivery device and method of delivery
10/07/2014US8851127 Methods and systems for pharmaceutical compounding
10/03/2014CA2847971A1 Stilbenoid compounds as inhibitors for squamous carcinoma and hepatoma and uses thereof
10/02/2014WO2014160989A2 Reperfusion with omega-3 glycerides promotes donor organ protection for transplantation
10/02/2014WO2014160956A2 Cartilage-binding fusion proteins
10/02/2014WO2014160947A1 Dimethylarginine dimethylaminohydrolase inhibitors and methods of use thereof
10/02/2014WO2014160940A2 Lipidic furan, pyrrole, and thiophene compounds for treatment of cancer, neurological disorders, and fibrotic disorders
10/02/2014WO2014160936A2 Thiazolidinediones of omega-3 polyunsaturated acids as new insulin sensitizers for treating type2 diabetes
10/02/2014WO2014160877A1 Prevention and treatment of kidney damage by bile acids
10/02/2014WO2014160873A1 Benzimidazolone derivatives as bromodomain inhibitors
10/02/2014WO2014160828A1 Bimatoprost ocular silicone inserts and methods of use thereof
10/02/2014WO2014160811A1 Compositions and methods for treating neuropathy
10/02/2014WO2014160810A1 6-(5-hydroxy-1h-pyrazol-1-yl)nicotinamide derivatives and their use as phd inhibitors
10/02/2014WO2014160783A1 2-halo-5-alkynyl-pyridyl nicotinic ligands
10/02/2014WO2014160775A1 Compositions and methods for the treatment of malaria
10/02/2014WO2014160729A1 Composition and method for treating cancer
10/02/2014WO2014160723A1 Compounds for the treatment of glioma
10/02/2014WO2014160702A1 Retinopathy treatment
10/02/2014WO2014160698A1 SOLID FORMS COMPRISING 4-AMINO-I-β-D-RIBOFURANOSYL-1,3,5-TRIAZIN-2(1H)-ONE AND A COFORMER, COMPOSITIONS AND METHODS OF USE THEREOF
10/02/2014WO2014160692A1 2-keto amide derivatives as hiv attachment inhibitors
10/02/2014WO2014160690A1 Solid forms comprising 4-amino-2-(2.6-dioxopiperidine-3-yl) isoindoline-1,3-dione and a coformer, compositions and methods of use thereof
10/02/2014WO2014160689A1 Piperazine and homopiperazine derivatives as hiv attachment inhibitors
10/02/2014WO2014160686A1 Solid forms comprising 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and a coformer, compositions and methods of use thereof
10/02/2014WO2014160683A2 Combination therapy for subcutaneous administration of glycopeptide antibiotics
10/02/2014WO2014160668A1 Tetrahydroisoquinolines containing substituted azoles as factor xia inhibitors
10/02/2014WO2014160638A1 Process of making prostacyclin compounds with linker thiol and pegylated forms
10/02/2014WO2014160633A1 Pharmaceutical compositions of dimethyl fumarate
10/02/2014WO2014160592A2 FACTOR XIa INHIBITORS
10/02/2014WO2014160579A1 Combination anti-inflammatory ophthalmic compositions
10/02/2014WO2014160521A1 Piperazine derivatives and their use as kit modulators
10/02/2014WO2014160502A1 Uridine nucleoside derivatives, compositions and methods of use
10/02/2014WO2014160480A1 Neuroactive steroids and methods of use thereof
10/02/2014WO2014160478A1 Compounds and methods for the treatment of cystic fibrosis
10/02/2014WO2014160440A1 Pyridazinone compounds and methods for the treatment of cystic fibrosis
10/02/2014WO2014160430A1 Small molecule lrrk2 and erk5 inhibitors
10/02/2014WO2014160423A1 Methods and compositions for correction of organ dysfunction
10/02/2014WO2014160409A1 Rbp4 antagonists for the treatment of age-related macular degeneration and stargardt disease
10/02/2014WO2014160405A1 Compounds, compositions comprising same, and methods related thereto
10/02/2014WO2014160401A1 3-(aryl or heteroaryl) methyleneindolin-2-one derivatives as inhibitors of cancer stem cell pathway kinases for the treatment of cancer
10/02/2014WO2014160392A1 Modified docetaxel liposome formulations
10/02/2014WO2014160387A2 Compositions, methods and devices for local drug delivery
10/02/2014WO2014160369A1 Combined systemic and topical treatment of disordered tissues
10/02/2014WO2014160360A1 Tubulysin compounds and conjugates thereof
10/02/2014WO2014160339A1 Compounds for treating inflammatory and hyperproliferative diseases
10/02/2014WO2014160337A1 Liposomal cisplatin compositions for cancer therapy
10/02/2014WO2014160335A1 Infant nutritional product with rrr alpha-tocopherol
10/02/2014WO2014160328A1 Mtor inhibitors for prevention of intestinal polyp growth
10/02/2014WO2014160286A1 Prenatal and lactation supplements to enhance central nervous system development of offspring
10/02/2014WO2014160279A1 Stabilized cream formulations comprising sandalwood oil
10/02/2014WO2014160243A1 Purification and purity assessment of rna molecules synthesized with modified nucleosides
10/02/2014WO2014160200A1 Ras inhibitors and uses thereof
10/02/2014WO2014160197A1 Thiazole compounds, compositions and methods for treatment of degenerative diseases and disorders
10/02/2014WO2014160196A2 Sonochemical induction of abca1 expression and compositions therefor
10/02/2014WO2014160183A1 Methods for modulating chemotherapeutic cytotoxicity
10/02/2014WO2014160181A1 Pyrazole compounds, compositions and methods for treatment of degenerative diseases and disorders
10/02/2014WO2014160167A1 Implantable drug delivery compositions comprising aromatic polyurethanes and methods of treatment thereof
10/02/2014WO2014160153A1 Treatment of a diastolic cardiac dysfunction with a trpv2 receptor agonist
10/02/2014WO2014160130A1 Combination therapy with 7-benzyl-10-(2-methylbenzyl)-2,6,7,8,9,10-hexahydroimidazo[1,2-a]pyrido[4,3-d]pyrimidin-5(3h)-one
10/02/2014WO2014160079A1 Microemulsion topical delivery platform
10/02/2014WO2014160077A1 Compositions to reduce pain comprising an opioid/toll-like receptor 4 antagonist, dextro enantiomers thereof, and methods of use therefor
10/02/2014WO2014160071A1 Methods and compositions for the treatment of glutamine-addicted cancers
10/02/2014WO2014160034A1 Aldehyde dehydrogenase-1 modulators and methods of use thereof
10/02/2014WO2014160031A1 Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto
10/02/2014WO2014160028A1 Pyrrolopyrimindine cdk9 kinase inhibitors
10/02/2014WO2014160017A1 Pyridine cdk9 kinase inhibitors
10/02/2014WO2014159999A1 Cdk9 kinase inhibitors
10/02/2014WO2014159993A1 Triazine compounds and compositions thereof and methods for treating malaria and chemoprophylaxis
10/02/2014WO2014159967A1 A composition for enhancing newborn infant cognitive, brain and/or cns development and method of using same
10/02/2014WO2014159959A1 Inhibitors of human immunodeficiency virus replication
10/02/2014WO2014159938A1 Substituted aminothiazoles for the treatment of tuberculosis
10/02/2014WO2014159937A1 Cyclic peptoid oligomers, pharmaceutical compositions and methods of using the same
10/02/2014WO2014159851A2 Novel low density lipoprotein nanocarriers for targeted delevery of omega-3 polyunsaturated fatty acids to cancer
10/02/2014WO2014159837A1 Methods and compositions for inhibition of bromodomain-containing proteins
10/02/2014WO2014159814A1 Formulations and tablets for treatment or prevention of neurological disorders
10/02/2014WO2014159813A1 Long-lived polynucleotide molecules
10/02/2014WO2014159812A1 Stabilization of essential oils within a hydrocolloid adhesive
10/02/2014WO2014159811A1 Salts and polymorphs of a compound
10/02/2014WO2014159802A1 Bicyclo [2.2.2] acid gpr120 modulators
10/02/2014WO2014159801A1 Enhanced drug delivery from adhesives
10/02/2014WO2014159775A1 Anti-clusterin monotherapy for cancer treatment
10/02/2014WO2014159772A2 Inhibition of the toxic effects of islet amyloid formation by fluriprofen and fluriprofen derivatives
10/02/2014WO2014159760A1 Liposome oxaliplatin compositions for cancer therapy
1 ... 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 ... 7860